Individuals Stopping Weight-Loss Injections Put On Pounds Far More Rapidly Than Those on Conventional Diets

Fresh analysis indicates that patients who come off blockbuster GLP-1 drugs like semaglutide or tirzepatide may regain lost weight far faster than those who stop conventional lifestyle plans.

Published data in a prominent health publication demonstrates that while obese people frequently drop substantial amounts of their total mass while using the jabs, the mass returns at an estimated rate of 0.8 kg per month after stopping.

"Users using such medications should be cognizant of the risk of quick rebound weight gain when the medication concludes," cautioned expert Dr. Susan Jebb.

Such speed of regain suggests a return to pre-treatment weight in about 18 months.

Analyzing Treatments

The research, which examined dozens of studies involving thousands of participants, compared the outcomes of the injectable medications with other pills.

Scientists point out that people who shed pounds through dieting usually see a less rapid weight regain—perhaps 0.1 kg a month—after stopping.

The Reason for the Fast Regain

Experts suggest the mode of action of the jabs explains the heightened weight return.

GLP-1 drugs mimic a body's own chemical called glucagon-like peptide-1, which moderates feelings of fullness.

"Long-term administration of GLP-1 concentrations far above than normal could lead to the body to produce less of its own natural GLP-1, and could diminish sensitivity to its actions," said Dr. Adam Collins, a nutrition expert.

"Withdrawal of this medication results in hunger is uncontrolled, making binge eating far more likely."

A Lifelong Issue?

Medical guidelines advise the jabs for people with weight-linked medical conditions, accompanied by prescribed lifestyle changes.

Many experts argue that, considering the significant potential of relapse, the therapy should be considered ongoing.

This view is reinforced by drug manufacturers, who say that the results "highlight the long-term character of excess weight," comparing it to managing conditions like hypertension.

User Experiences

People who have come off the medication report a sudden return of appetite.

"I experienced something activating and you're instantly starving," described a patient.

This difficulty is worsened if individuals have not established permanent lifestyle or habit modifications during therapy.

Growing Interest

Survey data show that millions of adults in the UK have tried weight-loss jabs in the last 12 months, with interest being substantial.

• Use is more common among females than men.
• The middle-aged demographic shows the greatest level of interest.
• Many obtain the medications through private healthcare rather than the NHS.

Ultimately, clinicians stress that while GLP-1 drugs are effective agents for shedding pounds, they are not a magic cure and maintained weight loss hinges on combined lifestyle support.